Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Indian Journal of Medical Microbiology|August 24, 2024
Development and validation of a pentaplex PCR assay for rapid detection of blaCTX-M, blaOXA-1, blaCMY, blaNDM and the PBP3 insert in EnterobacteralesYamuna Devi Bakthavatchalam, Fizaa Abdullah, Devishree Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3Sachin S Bhagwat, Periasamy Hariharan, Prashant R Joshi, et al.
Diagnostic Microbiology and Infectious Disease|March 7, 2022
In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019Yamuna Devi Bakthavatchalam, Abhisek Routray, Akshata Mane, et al.
Indian Journal of Medical Microbiology|May 9, 2018
Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend reportBalaji Veeraraghavan, Mark Ranjan Jesudason, John Antony Jude Prakasah, et al.
Mbio|October 27, 2023
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactamAndrea M Hujer, Steven H Marshall, Andrew R Mack, et al.
Infection Control and Hospital Epidemiology|January 4, 2024
Diving deep for the needle in the haystack: An outbreak investigation of Burkholderia cenocepacia bacteremiaAbdul Ghafur, Praveen Balaguru, S G Ramanan, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2025
In-vitro activity of cefepime/enmetazobactam against extended spectrum beta-lactamases and/or ampC producing Enterobacterales and Pseudomonas aeruginosa collected across IndiaYamuna Devi Bakthavatchalam, Abirami Shankar, Fiza Abdullah, et al.
Microbiology Spectrum|February 27, 2023
In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in IndiaYamuna Devi Bakthavatchalam, Divyaa Elangovan, Subha Vajjiravelu Jaganathan, et al.
International Journal of Antimicrobial Agents|March 7, 2026
Access to New Antibacterials in 10 Asian Countries: an Asian Network for Surveillance of Resistant Pathogens studyYoung Ho Lee, Helmi Bin Sulaiman, Visanu Thamlikitkul, et al.
Indian Journal of Medical Microbiology|December 12, 2022
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-careBalaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, et al.
Pageof 8